New - The Osstell Beacon supports implant stability
Osstell, the producer of the ISQ diagnostic technology (Implant Stability Quotient), has launched the next leap in the evolution of implant diagnostic instrumentation: The Osstell BeaconTM, an innovative and highly intuitive tool designed to guide implant treatments for more predictable results. Osstell’s patented technology allow clinicians working with implants to make decisions based on reliable and objective stability values when determining the course of treatment for each patient. The procedure can be used to measure primary implant stability, observe and monitor osseo-integration based on secondary stability readings and determine the best possible time for loading the implant, thereby helping to prevent failures, shortening healing time and ensuring high quality, whilst improving the treatment indications for higher risk patients.
The dental implant market has changed over the past few years. There are now more dentists with less experience within implantology and a generation shift so expectations are changing. Clinicians are facing more complex decisions as there is an increased number of patients presenting with higher risk factors in addition to an increasing demand for shorter treatment times. Digital planning and workflows are redefining protocols and techniques. There is thus a need for objective tools to increase efficiency, and to guide and optimize the implant treatment for both complex and more straight-forward cases, making ISQ diagnostics a necessary and objective key value to help improve outcomes and quality.
“We have listened to our users who need advanced technology in the form of an easy-to-use and intuitive complete product concept for the Osstell approach. Accordingly, we have developed a complement to the more comprehensive Osstell IDx to meet the needs of all practitioners, whether working inh large University clinics or smaller practices. For clinicians that are new to this method and technology, the feedback from the color coding, which essentially is an extract of all the scientific data that the Osstell ISQ scale is based on, will provide a guide as to when to load the implant.”, says Mr. Stefan Horn, VP Product Development, Osstell.
The Next Level in Implant Stability Measurement Instruments
In the industry today, there is a lot of talk about connectivity, utilising the digital options including internet to gather and save data. With this comes a strong need to, not only capture data, but also to be able to provide context to the numbers, making it useful and insightful. That’s why we are continuously focusing on enhancing connectivity and Osstell Connect, our online service allows you to analyze your data and get relevant insights of your implant treatment performance. We believe this will only become more and more valuable for the clinicians.”, continued Mr. Horn. Both the Osstell Beacon and the Osstell IDx give you access to Osstell Connect.
“Osstell’s innovative and patented technology allow dentists around the world to make dental implant treatments even safer and more predictable, thereby helping clinicians improve patient confidence and comfort. We always aim to serve our customers and users with even better products and services as well as helping them to provide best practice services to their customers – the patients. Patients’ well-being is always the top priority. With this – the Osstell Beacon, the newest addition to the range takes another important major step towards making our technology, products and our approach even more accessible”, says Mr Jonas Ehinger, CEO of Osstell.
The Osstell Beacon was launched at the Europerio 9 event in Amsterdam, Netherlands on June 20, 2018. Initially, it will be available in the EU and the US upon regulatory approval. Additional markets will follow pending regulatory approval processes.
Osstell is the global leader in implant stability measurement and osseo-integration progress monitoring. Osstell was formed in 1999 to commercialize an invention using Resonance Frequency Analysis (RFA) to determine the clinical status of a dental implants. Osstell’s proprietary and patented technology helps its customers, dentists around the world, make dental implant treatments predictable, by measuring the stability of implants objectively with resonance frequency by using the ISQ scale (Implant Stability Quotient). More than 900 scientific publications confirm the benefits of the technology, its clinical value, and the use of the ISQ scale for dentists in their daily practice. Osstell has its headquarters in Gothenburg, Sweden – the birthplace of dental implants. Osstell became a W&H Company in March 2018.